The Precision Peptide Company Targets Launch of the Peptide Pen, Expanding Its U.S.-Made Product Platform
Highlights The Company introduces expected launch of the Peptide Pen, its second commercial product, marking a significant expansion beyond transdermal patches into precision injection delivery Designed, manufactured, and tested in the United States in a cGMP-certified facility using medical-grade materials Features a 5mL dosing configuration, a first for a combined pen-and-vial peptide device, offering significantly more capacity than the standard 3mL cartri
2026-08-04 8:30 AM EDT | The Precision Peptide Company Inc.
TrustBIX Inc. Receives Final Exchange Acceptance of Acquisition of Zen Cyber Ltd.
Edmonton, Alberta--(Newsfile Corp. - August 4, 2026) - TrustBIX Inc. (TSXV: TBIX) ("TrustBIX" or the "Company") is pleased to announce that, further to its press releases dated February 24, 2026 and April 17, 2026, it has received final acceptance from the TSX Venture Exchange (the "TSXV") in connection with the acquisition of 100% of the issued and outstanding shares of Zen Cyber Ltd. ("Zen Cyber") (the "Transaction"). Zen Cyber is a cyberse
2026-08-04 7:15 AM EDT | TrustBIX Inc.
Green Rise Foods Provides Update on Strategic Review, Amended Credit Agreement, $1.581 Million Capital Injection and Production Update
Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - Green Rise Foods Inc. (TSXV: GRF) ("Green Rise" or the "Company") is pleased to make the following announcement: Strategic Review Update As previously announced on May 1, 2026, the Company initiated a strategic review process to identify, evaluate, and pursue potential strategic alternatives with the goal of maximizing shareholder value and liquidity (the "Strategic Review"). As part of the Strategic Review
2026-08-04 7:00 AM EDT | Green Rise Foods Inc.
Planet Based Foods Global Inc. Announces CFO Resignation, Appointment of Interim CFO, and Board Changes
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - Planet Based Foods Global Inc. (CSE: PBF) (OTC Pink: PBFFF) (FSE: AZ00) (the "Company" or "PBFG") announces that Supreet Bhullar, Chief Financial Officer of the Company, has resigned from her position, effective July 31, 2026. The Company thanks Ms. Bhullar for her contributions to PBFG and wishes her well in her future endeavours. PBFG also announces that Kerem Akbas, Chief Executive Officer of the Comp
2026-07-31 6:00 PM EDT | Planet Based Foods Global Inc.
Happy Belly Food Group's Heal Wellness QSR Announces the Grand Opening of its Newest Location in Country Hills, Calgary
Toronto, Ontario--(Newsfile Corp. - July 31, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands, is pleased to announce the grand opening of its newest Heal Wellness ("Heal") location, located at Unit 256 - 388 Country Hills Blvd, Calgary, this Saturday, August 1st, 2026. This location will be operated by a Happy Belly multi-unit multi-branded franchisee. The opening further expands
Food / Beverages, industries.restaurants.name
2026-07-31 8:40 AM EDT | Happy Belly Food Group Inc.
Purebread Brands Inc. Reports FY 2026 Results
Vancouver, British Columbia--(Newsfile Corp. - July 30, 2026) - Purebread Brands Inc. (TSXV: BRED) ("Purebread" or the "Company") is pleased to announce its financial results for the year ended March 31, 2026, the highlights of which are included in this news release. The full set of Cons
2026-07-30 8:30 AM EDT | Purebread Brands Inc.
The Precision Peptide Company Opens Nationwide Retail Sales Days After FDA Panel Backs Six of Seven Peptides Under Review
Highlights Seven products are now in stock and available to purchase at precisionpeptidecompany.com: BPC, KPV, Ageless, Chill, Blue, Hair and The Recovery Patch The Recovery Patch is the Company's first transdermal peptide product available at retail, providing a needle-free format that requires no mixing, no measuring and no cold storage All 50 U.S. states can order through t
2026-07-30 7:00 AM EDT | The Precision Peptide Company Inc.
Happy Belly Food Group's Rosie's Burgers Announces the Grand Opening of Its Newest Location in Edmonton's Brewery District
Toronto, Ontario--(Newsfile Corp. - July 30, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands, is pleased to announce the grand opening of its newest Rosie's Burgers ("Rosie's") restaurant this Saturday, August 1st, 2026 at noon, located at 10405 120th Street NW, Unit 6-106, in Edmonton's Brewery District. Rosie's is a boutique quick-service restaurant brand known for its sig
Food / Beverages, industries.restaurants.name
2026-07-30 6:00 AM EDT | Happy Belly Food Group Inc.
Happy Belly Food Group's Heal Wellness QSR Announces the Grand Opening of Its Newest Location in Georgetown, Ontario
Toronto, Ontario--(Newsfile Corp. - July 29, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands, is pleased to announce the grand opening of its newest Heal Wellness ("Heal") location, located at 152 Guelph Street in Georgetown, Ontario, this Saturday, August 1st, 2026. This location is being opened by the franchise group led by Alex Rechichi and Bedford Park Capi
Food / Beverages, industries.restaurants.name
2026-07-29 6:00 AM EDT | Happy Belly Food Group Inc.
Diamond Estates Wines & Spirits Reports Fiscal 2026 Financial Results
Niagara-on-the-Lake, Ontario--(Newsfile Corp. - July 28, 2026) - Diamond Estates Wines & Spirits Inc. (TSXV: DWS) ("Diamond Estates" or "the Company") today announced its financial results for the three and twelve months ended March 31, 2026 ("Q4 2026" and "FY 2026" respectively). FY 2026 Summary: Fiscal 2026 delivered another year of stronger results, driven by Winery growth in Ontario's expanded retail marketplace, ongoing
2026-07-28 6:09 PM EDT | Diamond Estates Wines & Spirits Inc.
The Precision Peptide Company Advances First-to-Market Thymosin Alpha-1 Patch for Immune Support
Highlights Q3/Q4 2026 is the targeted completion period for testing of The Precision Peptide Company's Thymosin Alpha-1 transdermal patch 2025 research continues to evaluate Thymosin Alpha-1 for immune regulation and inflammation, supporting its ongoing relevance within the peptide and immune-health landscape¹ The patch is being developed to bring Thymosin Alpha-1 into a portable, needle-free format without mixing or cold storage Ba
2026-07-28 7:00 AM EDT | The Precision Peptide Company Inc.
Happy Belly Food Group's Heal Wellness Announces It Has Secured a Real-Estate Location for King City, Ontario
Toronto, Ontario--(Newsfile Corp. - July 28, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands, is pleased to announce that its Heal Wellness brand ("Heal") has secured a real-estate location for its existing franchisee for King City, Ontario. This location further advances Heal's disciplined, asset-light growth strategy as the brand continues to expand across high-quality
Food / Beverages, industries.restaurants.name
2026-07-28 6:01 AM EDT | Happy Belly Food Group Inc.
Happy Belly Food Group Announces Release Date for Q2 2026 Financial Results
Toronto, Ontario--(Newsfile Corp. - July 27, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce that it intends to release its Q2 2026 unaudited financial results on Tuesday, August 25th, 2026, after market close. The Company's Second Quarter 2026 results will be disseminated on the Company's website (
Food / Beverages, industries.restaurants.name
2026-07-27 6:00 AM EDT | Happy Belly Food Group Inc.
The Precision Peptide Company Applauds FDA Advisory Committee Vote on Expanded Pathway for BPC-157 and KPV
On July 23, 2026, the FDA's Pharmacy Compounding Advisory Committee voted 8-6 (one abstention) to recommend BPC-157 for inclusion on the Section 503A Bulks List. BPC-157 was the first of seven peptides considered at the July 23-24 meeting. The Company markets a commercial portfolio of peptide products including KPV capsules and a BPC-157 transdermal patch. As per the Company's news release dated July 14, 2026, the Co
2026-07-24 7:00 AM EDT | The Precision Peptide Company Inc.
Happy Belly Food Group's Yolks Breakfast Secures Real-Estate Location in Edmonton's Brewery District
Toronto, Ontario--(Newsfile Corp. - July 22, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands, is pleased to announce that further to its press release dated October 31st, 2025, announcing the signing of a franchise agreement for the City of Edmonton, the Company has now secured a real-estate location for that franchisee in Edmonton's Brewery District. Yolks ("Yolks
Food / Beverages, industries.restaurants.name
2026-07-22 6:00 AM EDT | Happy Belly Food Group Inc.
The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch
Highlights The Precision Peptide Company's newly launched direct-to-consumer and telehealth platform is now available in all 50 states of the United States. 100% U.S.-compounded peptide products are supported through a 503A compounding agreement July 23, 2026 is the scheduled FDA advisory committee review date for several peptide substances, including BPC-157; The Precision Peptide Company's compounding, telehealth, compliance and consumer-sales
2026-07-21 7:00 AM EDT | The Precision Peptide Company Inc.
Above Food Provides Update on Nasdaq Listing Review Process and Engages Dickson Wright to Represent Company in Appeal
Regina, Saskatchewan--(Newsfile Corp. - July 17, 2026) - Above Food Ingredients Inc. (OTC: ABVEF) ("Above Food" or the "Company"), an agricultural and food technology company, today announced that it has engaged Dickinson Wright PLLC ("Dickinson Wright") to represent the Company in connection with its appeal before the Nasdaq Listing and Hearing Review Council. As previously announced, the Company has requested review of Nasdaq's prior delisting determination by the Nasdaq Listing and
2026-07-17 9:55 AM EDT | Above Food Ingredients Inc.
Happy Belly Food Group's Heal Wellness QSR Announces the Grand Opening of its Newest Location in Downtown Toronto, Ontario
Toronto, Ontario--(Newsfile Corp. - July 17, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands, is pleased to announce the grand opening of its newest Heal Wellness ("Heal") location, located at 14 York Street, in Toronto's downtown core, Ontario, on Saturday July 18th, 2026. This location is being opened by the franchise group led by Alex Rechichi and Bedford Park C
Food / Beverages, industries.restaurants.name
2026-07-17 6:00 AM EDT | Happy Belly Food Group Inc.
Happy Belly Food Group's Yolks Breakfast Secures Real-Estate Location in Nanaimo, British Columbia
Toronto, Ontario--(Newsfile Corp. - July 16, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands, is pleased to announce that its boutique breakfast brand, Yolks Breakfast ("Yolks"), has secured a real-estate location in Nanaimo, British Columbia. Yolks is a boutique restaurant brand serving delicious breakfast, brunch and lunch.
Food / Beverages, industries.restaurants.name
2026-07-16 6:00 AM EDT | Happy Belly Food Group Inc.
The Precision Peptide Company Inc. Announces Closing of LIFE Offering of Common Shares
Vancouver, British Columbia--(Newsfile Corp. - July 15, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), is pleased to announce that further to its news release dated June 11, 2026, it has closed its previously announced non-brokered private placement of common shares in the capital of the Company (the "Shares") at a price of $0.50 per Share under the Listed Issuer Financing Exemption (as defined herein) for gross proceeds of $2,00
2026-07-15 7:00 AM EDT | The Precision Peptide Company Inc.